Scientists from #MedUniVienna, #UniversityHospitalVienna, @cemm_news and @eth_en have published the first #personalisedmedicine study demonstrating clinical feasibility and efficacy of individualised therapy in #leukemia and #lymphoma patients: bit.ly/3aqrKIS

Here’s a thread with the take-home messages of our recent publication in #CancerDiscovery: For each patient, #Pharmacoscopy was used to test the ex-vivo drug response by calculating the relative #cancer fraction. The drug results were then considered in treatment decisions. 1/6

Vaikeaa verisyöpää sairastavien potilaiden hoitoa pystytään räätälöimään potilaan omien syöpäsolujen lääkeherkkyystestauksella. University of Helsinki & HUS Helsingin yliopistollinen sairaala Kimmo Porkka yhteistutkimuksen tulokset on julkaistu arvostetussa Cancer Discovery lehdessä. #syöpä #täsmähoito helsinki.fi/fi/uutiset/ter…

Was really great to finally meet again in-person with (most of) the EU JAKSTAT-Target and ERANET-PLL consortium members in beautiful Lyon. Great talks, productive discussions and amazing food!

ICYMI in Cancer Discovery: Functional Precision Medicine Provides Clinical Benefit in Advanced Hematological Cancers and Identifies #ExceptionalResponders Christoph Kornauth Tea Pemovska, PhD Giulio Superti-Furga Berend Snijder Philipp Staber et al MedUni Wien CeMM ETH Zurich #ASH21 cancerdiscovery.aacrjournals.org/content/early/…

Scientists from Giulio Superti-Furga's group at CeMM (Superti-Furga Lab) have used a drug library (CLIMET) to target a variety of metabolic pathways & identify sensitivities among 15 #MyeloidLeukemia cell lines, which could open future cancer therapy options ➡️ bit.ly/3pTejIM

Very honored to share our newest paper on targeting cancer cell metabolism in myeloid leukemias out today in Nature Communications. Thanks to all the collaborators and funders. Particularly Giulio Superti-Furga, Johannes Bigenzahn, Superti-Furga Lab & StaberLab. Conducted CeMM & MedUni Wien.

Check out the new study from the GSF Lab published in Nature Communications today with first author Tea Pemovska, PhD and collaborators from MedUni Wien where we show how vulnerabilities of cancer cell lines are determined through a collection of metabolic drugs.

curated drug screen cancer cells have weaknesses target these pathways #haiku #paperoftheday from Tea Pemovska, PhD, Giulio Superti-Furga, & colleagues in Nature Communications: nature.com/articles/s4146… #openaccess

Check out the papers featured on the cover of this month’s Cancer Discovery: Individualized therapies for hematologic malignancies. bit.ly/3JhHnSm By Christoph Kornauth, Tea Pemovska, PhD, Ingrid Simonitsch-Klupp, Giulio Superti-Furga, Berend Snijder, Philipp Staber, and colleagues ⬇

Super-proud that EXALT, our FPM study, was selected by The Cancer Discovery editors in this collection of impactful precision medicine articles: aacrjournals.org/collection/70/… Thanks to: Elizabeth McKenna, Cancer Discovery , Christoph Kornauth, Tea Pemovska, PhD, Greg Vladimer, Giulio Superti-Furga, Berend Snijder

Regulators, academics, investors and industry need to get together @theSFPM.

DAY1⃣ #ASCO22 Cancer Discovery OncoAlert 🚨Recap‼️ 5⃣Great papers presented by Elizabeth McKenna LINK🚫NO PAY WALL🧱 tinyurl.com/CDclinicaltria… Dana-Farber MD Anderson Cancer Center Mass General Cancer Center Christoph Kornauth Tea Pemovska, PhD Giulio Superti-Furga Berend Snijder Philipp Staber Gil Morgan, MD MedUni Wien Top Biomedical Science

Congratulations to Simona Saluzzo, @tpemovska and Andreas Kammerlander on the Dora Brücke-Teleky Awards! 🏆 With the award, our Alumni Club and the Gesellschaft der Ärzte in Wien - Billrothhaus honor publications by #postdocs. More about the papers and the award ceremony on 21 June! ➡️ bit.ly/3AwLdTD

Some great functional precision medicine here! The Society for Functional Precision Medicine

What therapies are used for aggressive #bloodcancer and #lymphoidcancer? And are they effective? Our #ResearcheroftheMonth Christoph Kornauth and @tpemovska from #MedUniVienna have established an innovative translational approach. Learn more! ➡️ bit.ly/3B287oo

A big thanks goes to all the patients, clinical partners and collaborators Philipp Staber, Christoph Kornauth, Tea Pemovska, PhD, Greg Vladimer, Giulio Superti-Furga, Exscientia and funding bodies ETH Zurich, DFG public | @[email protected], European Research Council (ERC) and Swiss National Science Foundation. 7/7

Today is International #WomenInScienceDay! 👩🔬 For today, we would like to shine the spotlight on our female #ResearcheroftheMonth from 2022. Congratulations to the #WomeninSTEM on their projects. To the collected videos! ➡️ bit.ly/3YvHMbr @womenscienceday

The Society for Functional Precision Medicine Great to see, early work of Tea Pemovska, PhD recognized in an excellent talk

Want to learn more about #functional precision medicine and meet world-leading experts? Join us in Copenhagen 25-27 Sept. 2024 for the EHA-SfPM Precision Medicine Meeting European Hematology Association The Society for Functional Precision Medicine . Abstract submission is still open. ehaweb.org/meetings/preci…